Skip to Content

Cancers, Volume 8, Issue 4

2016 April - 9 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (9)

  • Article
  • Open Access
46 Citations
9,587 Views
9 Pages

A Phase I Study of Unimolecular Pentavalent (Globo-H-GM2-sTn-TF-Tn) Immunization of Patients with Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First Remission

  • Roisin E. O’Cearbhaill,
  • Govind Ragupathi,
  • Jianglong Zhu,
  • Qian Wan and ,
  • Svetlana Mironov,
  • Guangbin Yang,
  • Maria K. Spassova,
  • Alexia Iasonos,
  • Sara Kravetz and
  • Paul J. Sabbatini
  • + 8 authors+ 3 authors

22 April 2016

We conducted a phase I study in ovarian cancer patients to evaluate the safety and immunogenicity of a synthetic unimolecular pentavalent carbohydrate vaccine (Globo-H, GM2, sTn, TF, and Tn) supported on a peptide backbone, conjugated to keyhole limp...

(This article belongs to the Special Issue Cancer Immunotherapies)
  • Review
  • Open Access
150 Citations
23,338 Views
22 Pages

KRAS Mutant Pancreatic Cancer: No Lone Path to an Effective Treatment

  • Daniel Zeitouni,
  • Yuliya Pylayeva-Gupta,
  • Channing J. Der and
  • Kirsten L. Bryant

18 April 2016

Pancreatic ductal adenocarcinoma (PDAC) is among the deadliest cancers with a dismal 7% 5-year survival rate and is projected to become the second leading cause of cancer-related deaths by 2020. KRAS is mutated in 95% of PDACs and is a well-validated...

  • Article
  • Open Access
8 Citations
7,210 Views
8 Pages

1 April 2016

We previously developed a new enzyme-targeting radiosensitization treatment named Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas, Type II (KORTUC II), which contains hydrogen peroxide and sodium hyaluronate for injection into various type...

(This article belongs to the Special Issue Drug/Radiation Resistance in Cancer Therapy)
  • Review
  • Open Access
50 Citations
10,155 Views
28 Pages

Radioresistance of Brain Tumors

  • Kevin Kelley,
  • Jonathan Knisely,
  • Marc Symons and
  • Rosamaria Ruggieri

30 March 2016

Radiation therapy (RT) is frequently used as part of the standard of care treatment of the majority of brain tumors. The efficacy of RT is limited by radioresistance and by normal tissue radiation tolerance. This is highlighted in pediatric brain tum...

(This article belongs to the Special Issue Drug/Radiation Resistance in Cancer Therapy)
  • Review
  • Open Access
104 Citations
11,809 Views
16 Pages

29 March 2016

Head and neck squamous cell carcinoma (HNSCC) is a highly heterogeneous disease that is the result of tobacco and/or alcohol abuse or infection with high-risk Human papillomaviruses. Despite the fact that HPV positive HNSCC cancers form a distinct cl...

(This article belongs to the Special Issue HPV Associated Cancers)
  • Article
  • Open Access
28 Citations
7,033 Views
9 Pages

Differential miRNA-Expression as an Adjunctive Diagnostic Tool in Neuroendocrine Tumors of the Lung

  • Melanie Demes,
  • Christoph Aszyk,
  • Holger Bartsch,
  • Joachim Schirren and
  • Annette Fisseler-Eckhoff

25 March 2016

Pulmonary malignancies with neuroendocrine differentiation represent a rare subclass of lung carcinomas, which vary in the extent of differentiation and grade of biological aggressiveness. In particular, neuroendocrine tumors are classified into well...

  • Review
  • Open Access
71 Citations
16,480 Views
15 Pages

Mitochondrial Redox Signaling and Tumor Progression

  • Yuxin Chen,
  • Haiqing Zhang,
  • Huanjiao Jenny Zhou,
  • Weidong Ji and
  • Wang Min

25 March 2016

Cancer cell can reprogram their energy production by switching mitochondrial oxidative phosphorylation to glycolysis. However, mitochondria play multiple roles in cancer cells, including redox regulation, reactive oxygen species (ROS) generation, and...

(This article belongs to the Special Issue Antioxidants in Cancer)
  • Article
  • Open Access
10 Citations
5,757 Views
9 Pages

NORE1A Regulates MDM2 Via β-TrCP

  • M. Lee Schmidt,
  • Diego F. Calvisi and
  • Geoffrey J. Clark

23 March 2016

Mouse Double Minute 2 Homolog (MDM2) is a key negative regulator of the master tumor suppressor p53. MDM2 regulates p53 on multiple levels, including acting as an ubiquitin ligase for the protein, thereby promoting its degradation by the proteasome....

(This article belongs to the Special Issue RASSF Signalling in Cancer)
XFacebookLinkedIn
Cancers - ISSN 2072-6694